Date Title Description PDF
27 Feb 2024 On P&L The Company releases the press release related to the full year 2023 financial results. Download
27 Feb 2024 On P&L The Company releases the full year 2023 financial results presentation. Download
27 Feb 2024 About Corporate Governance The Company informs about the agreements adopted by the Board of Directors Download
08 Nov 2023 On P&L The Company releases the press release related to the first nine months of 2023 financial results Download
08 Nov 2023 On P&L The Company releases the first nine months 2023 financial results presentation Download

Pages

Date Title Description PDF
05 Nov 2021 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted on 3 and 4 November Download
03 Nov 2021 On business and financial situation The Company releases the first nine months 2021 financial results presentation Download
03 Nov 2021 On business and financial situation The Company releases the press release related to the first nine months 2021 financial results Download
21 Oct 2021 Liquidity and counterparty agreements Download
21 Oct 2021 On business and financial situation The Company informs of the delay in the decision on Risperidone ISM® by the U.S. Food and Drug Administration (“FDA”). Download

Pages

Date Title Description PDF
28 Jul 2016 Información sobre resultados (2) ROVI releases the press release related to the 2016 first half results Download
28 Jul 2016 Información sobre resultados ROVI releases the presentation related to the 2016 first half results Download
05 Jul 2016 Contratos de liquidez y contrapartida Liquidity contract: transactions conducted in the second quarter of 2016 Download
24 Jun 2016 Información sobre dividendos The Company informs about the dividends payment Download
31 May 2016 Convocatorias y acuerdos de Juntas y Asambleas generales ROVI releases the information related to the agreements adopted by the 2016 General Shareholders Meeting Download

Pages